## MPC: Marathon Petroleum Corporation - XLE: Energy

### Executive Summary

VALUE thesis: PEG 0.92 indicates fundamental undervaluation. Quality metrics strong (ROE 19%). Consistent execution (3/4 quarters beat estimates). Caution: momentum weakening (-2.8% MRS).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($178.85)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 9
- **Sentiment:** Bullish (Bullish: 6, Bearish: 0)

**1. Barclays points to midstream stability in Marathon Petroleum (MPC) price target hike**
- Source: MSN | 20251203T210929 | Bullish | Relevance: 100%
- Barclays has increased its price target for Marathon Petroleum (MPC) to $220. The firm highlighted the stability provided by MPC's midstream segment, particularly MLPX, which is well-positioned for growing natural gas liquids (NGL) volumes. This stability helps balance the more volatile refining sector.

**2. Barclays Points to Midstream Stability in Marathon Petroleum (MPC) Price Target Hike**
- Source: Finviz | 20251203T143800 | Bullish | Relevance: 100%
- Barclays raised its price target on Marathon Petroleum (MPC) to $202 from $194 while maintaining an Overweight rating, updated after incorporating the latest commodities data. The firm highlighted MPC's strong third-quarter 2025 results, solid cash flow from its Refining and Marketing segment, and strategic actions in its Midstream business aimed at strengthening its portfolio and supporting mid-single-digit adjusted EBITDA growth. The company expects $2.8 billion in annualized distributions from MPLX to cover dividends and capital spending, viewing this as a competitive advantage.

**3. Barclays Points to Midstream Stability in Marathon Petroleum (MPC) Price Target Hike**
- Source: Insider Monkey | 20251203T143800 | Bullish | Relevance: 100%
- Barclays has increased its price target on Marathon Petroleum Corporation (MPC) to $202 from $194, maintaining an Overweight rating, citing the company's strong midstream stability. This update followed Marathon Petroleum's third-quarter 2025 results, which reported $1.4 billion in net income, and highlighted robust cash flow from its Refining and Marketing segment and anticipated mid-single-digit adjusted EBITDA growth from its Midstream business. The company's strategic capital deployment focuses on high-return projects and initiatives to improve margins and lower costs across its refining operations.

**4. Marathon Petroleum Corporation $MPC Shares Sold by OMERS ADMINISTRATION Corp**
- Source: MarketBeat | 20251203T124803 | Somewhat-Bullish | Relevance: 100%
- OMERS ADMINISTRATION Corp reduced its stake in Marathon Petroleum (NYSE:MPC) by 35.6% in Q2, selling 9,110 shares. Despite this, other major institutions like Vanguard and Norges Bank significantly increased their holdings, pushing institutional ownership to 76.77%. Marathon Petroleum also raised its quarterly dividend to $1.00 per share and reported a slight EPS beat with strong revenue, while analysts maintain a "Hold" rating with an average target price of $203.21.

**5. Grantham Mayo Van Otterloo & Co. LLC Acquires Shares of 6,766 Marathon Petroleum Corporation $MPC**
- Source: MarketBeat | 20251202T092731 | Bullish | Relevance: 100%
- Grantham Mayo Van Otterloo & Co. LLC has acquired 6,766 shares of Marathon Petroleum Corporation (MPC) valued at approximately $1.124 million, establishing a new position in the company during the second quarter. Other institutional investors also adjusted their holdings in MPC, with overall institutional ownership now standing at 76.77%. Marathon Petroleum recently increased its quarterly dividend to $1.00 per share and reported strong Q3 earnings with EPS beating estimates and revenue exceeding expectations.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 2, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-17 | Barclays | $202 | $194 | +4% |
| 2025-11-14 | Piper Sandler | $231 | $220 | +5% |
| 2025-11-05 | Wells Fargo | $213 | $214 | -0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-17 | Barclays | main | Overweight |
| 2025-11-14 | Piper Sandler | main | Neutral |
| 2025-11-05 | Wells Fargo | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 6 ($0.19M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 41.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 3 / 7 |

**Top Holders:**
- Vanguard Group Inc: 12.8% (-1.3%)
- Blackrock Inc.: 7.5% (-4.3%)
- State Street Corpora: 5.9% (-3.0%)
- Wellington Managemen: 3.1% (-19.8%)
- Geode Capital Manage: 2.6% (-1.1%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-2.8% 5d) with bearish MACD, trend may be turning.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 0.92 indicates undervaluation relative to growth. Forward P/E 13.4x attractive for 39% earnings growth. Balance sheet: $1.7B free cash flow. Revenue declining -6% YoY, concerning. Institutional flow bullish (3 buying vs 7 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $49.8B |
| Beta | 0.72 |
| 52W Range | $115.10 - $202.30 |
| Short Interest | 3.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.92 |
| Forward P/E | 13.4 |
| Current P/E | 18.6 |
| YoY Growth | 39.3% |
| EPS Direction | RISING |

### Technicals

MRS_20 deteriorating from -0.9% to -3.8% (-2.8% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 7.8pp (needs >4.0% for momentum thesis). Underperforming sector by 3.8pp, stock-specific weakness. Long-term uptrend intact (above SMA200 at 1.14x) but short-term weakness (below SMA20). MACD histogram bearish (-0.62), momentum weakening. RSI neutral at 47. OFD pattern: +SUN (Resistance test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -3.76% (CS: 16) | Weak |
| RSI_14 | 47.1 | Neutral |
| MACD Histogram | -0.62 | Bearish |
| vs SMA20 | 0.981x | Below |
| vs SMA50 | 0.992x | Below |
| vs SMA200 | 1.138x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $190.15
- **Stop Loss:** $178.85 (5.9% risk)
- **Target:** $212.75 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 88
- **Position Value:** $16,733.20
- **Portfolio %:** 16.73%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate risk appetite and mixed signals. VIX at 15.78 indicates calm conditions but breadth at 53% suggests narrow participation. Fed policy remains neutral with 42 days to next meeting, supporting steady positioning with sector selectivity.*

### Earnings

**Next:** 2026-02-03 (Est: $3.64)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $3.16 | $3.01 | -4.9% |
| 2025Q2 | $3.22 | $3.96 | +23.0% |
| 2025Q1 | $-0.54 | $-0.24 | +55.8% |
| 2024Q4 | $0.02 | $0.77 | +3730.9% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*